CVS Health Corporation CVS

89.13 4.08 4.80% as of 25 Sep
Market cap
$108.5B
P/E
23.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

CVS Health Corporation (CVS) EV/Sales

As of 25 September 2026, CVS Health Corporation (CVS) trades at a EV/Sales of 0.4×. Over the past ten years it has ranged from 0.3× (January 2025) to 1.0× (July 2015); the current reading is higher than 18% of that period. That is above the Healthcare Plans industry median of 0.4× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 0.4× 28.14%
FY2024 0.3× (30.35%)
FY2023 0.4× (12.35%)
FY2022 0.5× (20.14%)
FY2021 0.6× 15.44%
FY2020 0.5× (12.88%)
FY2019 0.6× (12.00%)
FY2018 0.7× 28.20%
FY2017 0.5× (12.72%)
FY2016 0.6× (29.05%)

Quarterly

Period EV/Sales Change
Jun 2026 0.4× 23.78%
Mar 2026 0.3× (8.95%)
Dec 2025 0.4× 0.79%
Sep 2025 0.4× 5.56%
42 more quarters

Against its own ten years

Low 0.3× High 1.0×
Ten-year median 0.5×
Current reading's percentile 18

EV/Sales against peers

Company EV/Sales
CNC Centene Corporation compare 0.1×
MOH Molina Healthcare, Inc compare 0.1×
HUM Humana Inc. compare 0.3×
CI Cigna Group compare 0.3×
OSCR Oscar Health, Inc. compare 0.3×
CVS CVS Health Corporation 0.4×
ELV Elevance Health, Inc. compare 0.4×
UNH UnitedHealth Group Incorporated compare 0.8×
CLOV Clover Health Investments, Corp. compare 0.9×
Healthcare Plans industry median 0.4×
Healthcare sector median 3.6×
Market median 2.2×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on CVS